《临床研究杂志》.2004年.第4期

　

• A brand-new bird: how two amateur scientists created the first genetically engineered animal
• Assessing risk is the business of prion disease research
• Assessing risk is the business of prion disease research
• Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease
• Fighting cancer by disrupting C-terminal methylation of signaling proteins
• HDLaction on the vascular wall: is the answer NO?
• Human African trypanosomiasis of the CNS: current issues and challenges
• Into the depths of ataxia
• Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis
• The eosinophil enigma